AI-generated summary
The authors studied 20 adults with melasma treated four times monthly with a 1064 nm picosecond laser using a fractionated microbeam array. Blinded dermatologists rated images as improved at 3 and 8 months, and most subjects reported satisfaction, though the authors' conclusion of safety and effectiveness rests on this small, uncontrolled sample.
- Participants
- 20
- Who or what was studied
- Twenty adults with a clinical diagnosis of melasma
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The abstract describes a small sample with no control group, and assessments relied on image ratings and subject self-assessment.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1064 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.